Timing of Invega Administration

Rationale for Dosing Timing

The American College of Physicians and other guideline societies may recommend adjusting dosing times for sedating medications, such as paliperidone, to minimize daytime sedation and functional impairment, though specific recommendations are not provided here 1

Switching to bedtime administration of paliperidone is a reasonable strategy for patients experiencing significant daytime sedation despite morning dosing, to align peak sedative effects with sleep time 1
Olanzapine is recommended at bedtime (2.5-5 mg) when used for insomnia in palliative care settings, according to the National Comprehensive Cancer Network 2, 3, 4
Quetiapine at bedtime (25-100 mg) is commonly used for sedation, though guidelines caution about metabolic risks, as noted by the National Comprehensive Cancer Network 5, 6, 1
Administering sedating medications 1-2 hours before desired sleep time aligns peak effects with bedtime, as suggested by Praxis Medical Insights 1

The National Comprehensive Cancer Network recommends monitoring for extrapyramidal symptoms (EPS), which increase in a dose-related manner with paliperidone, including the need for anticholinergic medications 3
Orthostatic hypotension risk exists with paliperidone, regardless of timing, as noted by Praxis Medical Insights 1

Assessing sedation impact after 1-2 weeks of stable dosing is recommended, according to the National Comprehensive Cancer Network 4
If significant daytime sedation impairs function, switching to bedtime dosing (1-2 hours before sleep) is a reasonable strategy, as suggested by Praxis Medical Insights 1